% alzhub.org library filter
% Source: https://alzhub.org/research?author=Farlow+MR&atag=randomized
% 10 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{tariot2004-14734594,
  author  = {Tariot, P. N. and Farlow, M. R. and Grossberg, G. T. and Graham, S. M. and McDonald, S. and Gergel, I. and {Memantine Study Group}},
  title   = {{Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2004},
  doi     = {10.1001/jama.291.3.317},
  pmid    = {14734594},
  url     = {https://doi.org/10.1001/jama.291.3.317}
}

@article{rogers1998-9443470,
  author  = {Rogers, S. L. and Farlow, M. R. and Doody, R. S. and Mohs, R. and Friedhoff, L. T.},
  title   = {{A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group}},
  journal = {Neurology},
  year    = {1998},
  doi     = {10.1212/wnl.50.1.136},
  pmid    = {9443470},
  url     = {https://doi.org/10.1212/wnl.50.1.136}
}

@article{wagemann2024-38683602,
  author  = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others},
  title   = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.0991},
  pmid    = {38683602},
  url     = {https://doi.org/10.1001/jamaneurol.2024.0991}
}

@article{siemers2006-16505324,
  author  = {Siemers, E. R. and Quinn, J. F. and Kaye, J. and Farlow, M. R. and Porsteinsson, A. and Tariot, P. and Zoulnouni, P. and Galvin, J. E. and others},
  title   = {{Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease}},
  journal = {Neurology},
  year    = {2006},
  doi     = {10.1212/01.wnl.0000198762.41312.e1},
  pmid    = {16505324},
  url     = {https://doi.org/10.1212/01.wnl.0000198762.41312.e1}
}

@article{fleisher2008-18695053,
  author  = {Fleisher, A. S. and Raman, R. and Siemers, E. R. and Becerra, L. and Clark, C. M. and Dean, R. A. and Farlow, M. R. and Galvin, J. E. and others},
  title   = {{Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.8.1031},
  pmid    = {18695053},
  url     = {https://doi.org/10.1001/archneur.65.8.1031}
}

@article{henderson2015-26537053,
  author  = {Henderson, V. W. and Ala, T. and Sainani, K. L. and Bernstein, A. L. and Stephenson, B. S. and Rosen, A. C. and Farlow, M. R.},
  title   = {{Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000002171},
  pmid    = {26537053},
  url     = {https://doi.org/10.1212/wnl.0000000000002171}
}

@article{schneider2005-16375657,
  author  = {Schneider, L. S. and DeKosky, S. T. and Farlow, M. R. and Tariot, P. N. and Hoerr, R. and Kieser, M.},
  title   = {{A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type}},
  journal = {Current Alzheimer research},
  year    = {2005},
  doi     = {10.2174/156720505774932287},
  pmid    = {16375657},
  url     = {https://doi.org/10.2174/156720505774932287}
}

@article{farlow2001-11255445,
  author  = {Farlow, M. R. and Hake, A. and Messina, J. and Hartman, R. and Veach, J. and Anand, R.},
  title   = {{Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.417},
  pmid    = {11255445},
  url     = {https://doi.org/10.1001/archneur.58.3.417}
}

@article{aisen2003-12783912,
  author  = {Aisen, P. S. and Schafer, K. A. and Grundman, M. and Pfeiffer, E. and Sano, M. and Davis, K. L. and Farlow, M. R. and Jin, S. and others},
  title   = {{Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2003},
  doi     = {10.1001/jama.289.21.2819},
  pmid    = {12783912},
  url     = {https://doi.org/10.1001/jama.289.21.2819}
}

@article{cummings2010-20502014,
  author  = {Cummings, J. L. and Ferris, S. H. and Farlow, M. R. and Olin, J. T. and Meng, X.},
  title   = {{Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2010},
  doi     = {10.1159/000296073},
  pmid    = {20502014},
  url     = {https://doi.org/10.1159/000296073}
}